MedPath

Remote Cognitive Behavioural Therapy (CBT) for Anxiety Disorders in Lesbian, Gay, Bisexual, Transgender, Queer, Questioning, and Non-Heterosexual or Non-Cisgender (LGBTQ+) People

Not Applicable
Recruiting
Conditions
Anxiety Disorders
Mental Health - Anxiety
Registration Number
ACTRN12624000453583
Lead Sponsor
niversity of Technology Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
52
Inclusion Criteria

The randomised control trial and qualitative semi-structured interviews will utilise the following inclusion criteria:
(1) Presently residing in Australia;
(2) Aged 18 years or over;
(3) Fluent in English;
(4) Meets criteria for an anxiety disorder as either the primary diagnosis (or co-primary with a depressive disorder) and the disorder is of at least ‘moderate severity’ (defined as a score of 4 on the Diagnostic Interview for Anxiety, Mood, and Obsessive-compulsive and Related Neuropsychiatric Disorders [DIAMOND] module severity measure);
(5) Medication-free or on a stable dose (8 weeks) of psychotropic medication; and
(6) Not presently receiving regular psychological services for their anxiety symptoms (defined as sessions at least once a week with a qualified mental health professional);
(7) Identify as LGBTQ+; and
(8) Have access to a private location to complete the treatment for the duration of the study.

Exclusion Criteria

(1) Suicide risk as assessed by item 9 of the PHQ-9 (a score of 2 or above) at baseline, the Columbia Suicide Severity Rating Scale, or via clinician judgement during the diagnostic interview.
(2) Engagement in non-suicidal self-injury in the past 12 months;
(2) Daily use of alcohol or illicit drugs (meaning illegal drugs, pharmaceutical drugs used outside of their prescribed or intended use, and other substances inappropriately used);
(3) The presence of a schizophrenia spectrum disorder as assessed by the DIAMOND semi-structured clinical interview;
(4) Any significant cognitive/intellectual impairment as assessed during the diagnostic interview;
(5) A medical condition that may interfere with treatment;
(6) No access to a computer with a camera and stable internet on a regular basis;
(7) Is not willing to engage in treatment on a regular basis using internet-videoconferencing software;
(8) Does not explicitly identify as LGBTQ+;and
(9) Does not indicate any anxiety disorder symptoms on the DIAMOND Self Report screener.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety disorder severity and associated impairment [Overall Anxiety Severity and Impairment Scale (OASIS; Norman et al., 2006) Pre-treatment, mid-treatment (week 4), post-treatment (week 9, primary endpoint), and 3-month follow-up after treatment completion.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath